Author

Natalie M. Elliott

Mayo ClinicORCID 0000-0002-4130-1286Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Molecular Biology· 1 Neuroscience· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:mouse· 3 Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Assay:spatial transcriptomics· 1

Frequent Co-Authors

Aleksandra CiosiD· 2 shared Bolni Marius NagaloiD· 2 shared Elizabeth A. RaupachiD· 2 shared Khandoker Usran Ferdous· 2 shared Mitesh J. BoradiD· 2 shared Alex T Baker· 1 shared Alexei G. BasnakianiD· 1 shared Alicja Joanna UrbaniakiD· 1 shared

Activity by Year

2025-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 39 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Aleksandra CiosORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

NeurosciencebioRxivPreprintOct 22, 2026

Sex-Dependent Effects of Creatine Hydrochloride on Neuroinflammation, Neuronal Survival, and Inhibitory Synaptic Remodeling Following Traumatic Brain Injury in Mice.

Johnny W. Zigmond, Benjamin G. Lamberty, Gretchen J Simon…·Kelly L. Stauch

This study investigates the neuroprotective effects of Creatine Hydrochloride (C-HCl) on traumatic brain injury (TBI) in mice, finding sex-dependent benefits in reducing neuroinflammation, neurodegeneration, and inhibitory synaptic remodeling.

DOI 10.64898/2026.10.21.760461

mouseexperimental assay

Cancer BiologyJournal for ImmunoTherapy of CancerPeer-reviewedMay 1, 2026

Pancreatic tumor microenvironment reprogramming via alloantigen-expressing virotherapy elicits tumor rejection and improves immunotherapy response

Mulu Z. Tesfay, Aleksandra Cios, Zetao Cheng…·Bolni Marius Nagalo

Oncolytic virus-based delivery of an alloantigen improves antitumor immunity and synergizes with immune checkpoint inhibitors in pancreatic cancer.

1 citation

mousespatial transcriptomics

Molecular BiologybioRxivPreprintAug 1, 2025

Repeat Systemic Delivery of Cross-Neutralization Resistant Synthetic Vesiculoviruses Immunomodulates the Tumor Microenvironment

Natalie M. Elliott, Benjamin Luke Kendall, Souyma Dutta…·Mitesh J. Borad

A glycoprotein-engineered vesiculovirus platform circumvents neutralizing antibodies, enabling repeat intravenous dosing and sustained anti-tumor immunity in preclinical models.

1 citation

mouseexperimental assay